ArticleArchives of virology2025
Exchanging the stem-loop A promoter of Zika virus with the corresponding region of tick-borne encephalitis virus generates a chimeric virus that replicates in vertebrate and mosquito cells.
Article in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- The RNA promoter for pathogenic orthoflaviviruses replication is universal and serves as target for viral inhibition.PLoS pathogens · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The 5' end of the orthoflavivirus genome contains a stem-loop structure, known as stem-loop A (SLA), which interacts with the viral polymerase (the NS5 protein) and functions as the promoter during RNA replication. Previously, we replaced the SLA of Zika virus (ZIKV; a mosquito/vertebrate orthoflavivirus) with the corresponding region of Long Pine Key virus (a dual-host-associated insect-specific orthoflavivirus), producing a chimeric virus capable of replicating in both mosquito and vertebrate cells. Here, we investigated whether additional chimeric viruses could be created by replacing the SLA of ZIKV with those of other orthoflaviviruses that are maintained in different transmission cycles, namely: tick-borne encephalitis virus (TBEV; a tick/vertebrate orthoflavivirus), Culex flavivirus (a classical insect-specific orthoflavivirus), Modoc virus (a rodent-associated vertebrate-specific orthoflavivirus), and Rio Bravo virus (a bat-associated vertebrate-specific orthoflavivirus). Exchanging the SLA of ZIKV with that of TBEV produced a chimeric virus capable of replicating in mosquito and vertebrate cells, whereas the other SLA replacements did not yield infectious virus. The chimeric virus replicated more slowly, reached lower titers, and produced smaller plaques than wild-type ZIKV in vertebrate cells. The chimeric virus also exhibited reduced fitness in mosquito cells. These findings demonstrate that replacement of the SLA of ZIKV with the corresponding region of TBEV produces a chimeric virus that replicates in both mosquito and vertebrate cells, revealing that ZIKV NS5 is able to recognize and bind to the TBEV promoter, rendering it active. This study highlights the importance of SLA-polymerase compatibility in flavivirus replication and provides insight into the molecular basis of host adaptation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.